
When insulin and other biological products are stored outside the recommended temperature range (2°C to 8°C for unopened products), their protein structures become denatured, leading to a reduction or complete loss of therapeutic activity. In many cases, the medication may be compromised without showing any visible signs, posing a risk of difficult-to-control hyperglycemia and constituting a violation of pharmaceutical storage standards




